Retinal degenerative diseases theme of StemCellTalks 2019

by Guest | Mar 13, 2019

Eleni Kanavas is a science communicator with more than eight years of work experience in the academic and health science fields. She is the Acting Communications Specialist at CCRM. She completed her Honours Bachelor’s Degree in Journalism at the University of Toronto...

International Women’s Day: Why does representation matter in Canadian research?

by Farah Qaiser | Mar 8, 2019

Today is International Women’s Day. This year, the theme is “think equal, build smart, and innovate for change,” to ensure that women’s needs and experiences are considered when it comes to innovation. While real progress has been made when it comes to gender...

Without new funding, key part of Canada’s stem cell research ecosystem to close

by Sowmya Viswanathan | Feb 28, 2019

Cindi Morshead is a professor and chair of the anatomy division of the Department of Surgery with the University of Toronto, with appointments in the Institute of Biomaterials and Biomedical Engineering and the Toronto Rehabilitation Institute. Sowmya Viswanathan is...

Medicine by Design-funded researchers devise new strategy to improve the safety of cell therapies

by Lisa Willemse | Feb 22, 2019

Please click here to read the original version of the article that first appeared on Medicine by Design’s site and is reprinted with permission. The article has been edited slightly for length. A contagious facial cancer that has ravaged Tasmanian devils in southern...

Right Turn: Curing Canavan Disease with gene therapy

by Stacey Johnson | Feb 15, 2019

Rare diseases are defined as such because the number of people affected by them is considered very low. Depending on which country you live in, that number will change. There are so many rare diseases in the world that if you add up the number of people living with...

Meet Dr. Heidi Gardner: the force behind Science On A Postcard

by Guest | Feb 5, 2019

Farah Qaiser is a graduate student at the University of Toronto, where her research involves whole-genome sequencing of patients with neurological disorders. When not in the lab, Farah dabbles in various science communication, policy and outreach initiatives. You can...

Right Turn: Are we facing a COGs crisis? Some moments from Phacilitate 2019

by Stacey Johnson | Feb 1, 2019

There is no denying that the joining of Phacilitate Leaders World and World Stem Cell Summit has resulted in a grand buffet of tasty treats to appeal to an assortment of consumers. For the second year, the two conferences have attracted academics, industry,...

The great experiment: CAR T in Canada

by Erika Siren | Jan 23, 2019

September 5th, 2018, marked a momentous day for Canadian health care as Novartis announced Health Canada’s approval of Kymriah™, the first genetically manipulated cell therapy to be approved in Canada. With the ability of CAR Ts like Kymriah to treat and, potentially...

Right Turn: Please read this blog

by Stacey Johnson | Jan 18, 2019

  You know how you’ve made a resolution for 2019 that will make you a better, happier person? Well did you know last Friday (January 12) was the day when most people give up on their resolutions, according to the Independent, reporting on a new study?...

Right Turn: Churchill, Marx (Groucho!) and appealing to a scientist’s vanity

by Stacey Johnson | Jan 11, 2019

It’s a new year and my email inbox is brimming with invitations addressed to “Dr.” Stacey Johnson to be a speaker at a scientific conference, be on a scientific editorial board, submit an article based on my research – you get the idea. So what, you say? You also get...